MedPath
NMPA Approval

Compound Paracetamol and Chlorphenamine Maleate Granules

国药准字H43021855

February 1, 2024

Drug Information

复方氨酚那敏颗粒

颗粒剂

复方

化学药品

February 1, 2024

Company Information

Applicant Company

长沙市高新区麓松路789号

Manufacturing Company

湖南省长沙市麓松路789号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨酚那敏颗粒 - NMPA 批准文号 | MedPath